European Society of Cardiology
Welcome to the European Society of Cardiology
 
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Our mission: to reduce the burden of cardiovascular disease in Europe
 

European Heart Rhythm Association (EHRA)

To improve the quality of life of the European population by reducing the impact of cardiac arrhythmias and reduce sudden cardiac death.

Attend EHRA-EUROPACE 2011, the official congress of the European Heart Rhythm Association (EHRA)

Latest update on the status of cardiac electrophysiology in ESC member countries

The 2010 EHRA White Book edition is now published!

It is part of the task and privilege of EHRA to foster scientific discussion, create standards for education and training and offer help wherever necessary to harmonize treatment and access to the treatment of arrhythmias within its hemisphere.

Download the full edition or access data from a country.

EHRA-EUROPACE 2011 scientific programme: What's new?

Next year congress will feature some new attractive scientific sessions:

Live Case Symposia, How-to session/ Mini Course, Techno Forum and more....

Find out what it is about and plan your attendance ahead.

Learn more about the EHRA Research Summit held at the European Heart House on 23-24 Sept. 2010
Bring together committed research leaders who will identify key research areas in cardiac arrhythmia management.

EHRA Summit 2010: E-health and personalised health care in arrhythmias

Highlight on...

 Trust and Security
Marc Dacier

 Bridging the chasm between ICT specialists and clinicians
W. Ed Hammond

Arrhythmia highlights - Our web committee's choice

  • Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions.
    Mollerus M et al. Europace. 2010;.12(7): 947-951. Read more
  • Dronedarone in patients with congestive heart failure: insights from ATHENA .
    Hohnloser SH et al for the ATHENA Investigators. Eur Heart J. 2010; 31(14): 1717-1721 doi:10.1093/eurheartj/ehq113. Read more
  • An entirely subcutaneous implantable cardioverter-defibrillator.
    Bardy GH et al. N Engl J Med. 2010; 363(1): 36-44. Read more
  • Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation.
    Sawhney N et al. Circ Arrhythm Electrophysiol. 2010; 3(3): 243-248. Read more
  • Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
    Di Biase L et al. Circulation. 2010; 121(23): 2550-2556. Read more